Glenmark Pharmaceuticals Reports Data Security Incident in Indiana

Glenmark Pharmaceuticals Inc USA, a global pharmaceutical company, reported a data security incident to the Indiana Attorney General on March 17, 2026. The company disclosed that unauthorized access to its systems occurred on February 27, 2026.

According to the official filing, this incident means that personal information maintained by Glenmark Pharmaceuticals may have been accessed without authorization. The specific types of data involved in this breach were not detailed in the public record.

If you received a notification letter from Glenmark Pharmaceuticals, it signifies that your information was potentially involved in this security event. These letters are sent directly by the company to inform affected individuals about the incident and recommend protective measures.

Individuals who have received a notification should carefully review the letter for any specific advice provided by Glenmark Pharmaceuticals. It is generally wise to remain vigilant for unusual activity across your online accounts and financial statements. Consider enabling multi-factor authentication wherever possible.

This information is based on public filings made by Glenmark Pharmaceuticals with the Indiana Attorney General. The company has indicated that an investigation into the incident is ongoing.